| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.46M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 14,914 | $59.67 | $889,906.75 | -51.7% | |
| Jun 23, 2020 | Berthelsen Spencer R | Director | Sale+OE | 15,000 | $58.76 | $881,400.00 | -13.4% | |
| Jun 19, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 27,000 | $58.08 | $1,568,271.00 | -36.3% | |
| Mar 25, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 16,000 | $47.00 | $752,000.00 | -25.2% | |
| Mar 19, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 16,000 | $45.16 | $722,546.00 | -11.4% | |
| Mar 17, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 20,390 | $44.75 | $912,355.00 | -6.1% | |
| Feb 10, 2020 | O'Neil Patrick R.57 | SVP &General Counsel | Sell | 3,882 | $59.60 | $231,367.20 | -15.8% | |
| Jan 2, 2020 | Monia Brett P60 | Chief Executive Officer | Sell | 173 | $60.25 | $10,423.25 | -1.1% | |
| Dec 23, 2019 | Klein Joseph III60 | Director | Sale+OE | 1,000 | $61.87 | $61,874.20 | -7.3% | |
| Dec 16, 2019 | Klein Joseph III60 | Director | Sale+OE | 1,000 | $65.45 | $65,446.50 | -7.3% |